Total Payments
$233,442
2024 Payments
$28,096
Companies
16
Transactions
104
Medicare Patients
1,001
Medicare Billing
$52,877
Payment Breakdown by Category
Consulting$199,970 (85.7%)
Travel$28,720 (12.3%)
Other$2,500 (1.1%)
Food & Beverage$2,252 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $199,970 | 39 | 85.7% |
| Travel and Lodging | $28,720 | 31 | 12.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,500 | 1 | 1.1% |
| Food and Beverage | $2,252 | 33 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $87,301 | 20 | $0 (2024) |
| Amgen Inc. | $70,178 | 15 | $0 (2020) |
| Mallinckrodt Hospital Products Inc. | $25,800 | 4 | $0 (2021) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $11,387 | 11 | $0 (2024) |
| Shire North American Group Inc | $7,171 | 20 | $0 (2017) |
| Daiichi Sankyo Company LTD | $6,105 | 1 | $0 (2020) |
| GlaxoSmithKline, LLC. | $6,043 | 6 | $0 (2024) |
| Travere Therapeutics, Inc. | $5,606 | 4 | $0 (2024) |
| Janssen Research & Development, LLC | $5,449 | 2 | $0 (2017) |
| Mallinckrodt LLC | $4,065 | 7 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,096 | 27 | Novartis Pharmaceuticals Corporation ($11,932) |
| 2023 | $74.99 | 1 | NOVARTIS PHARMACEUTICALS CORPORATION ($74.99) |
| 2022 | $19,056 | 5 | Novartis Pharmaceuticals Corporation ($16,800) |
| 2021 | $53,910 | 10 | Novartis Pharmaceuticals Corporation ($36,545) |
| 2020 | $38,605 | 6 | Novartis Pharmaceuticals Corporation ($14,000) |
| 2019 | $26,764 | 8 | Amgen Inc. ($22,567) |
| 2018 | $49,251 | 17 | Amgen Inc. ($45,111) |
| 2017 | $17,685 | 30 | Shire North American Group Inc ($7,171) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $235.54 | General |
| Category: Nephrology | ||||||
| 10/28/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Nephrology | ||||||
| 10/28/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Nephrology | ||||||
| 10/28/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Nephrology | ||||||
| 10/26/2024 | Novo Nordisk Health Care AG | — | Food and Beverage | In-kind items and services | $44.52 | General |
| 10/22/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $105.94 | General |
| 06/21/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 04/14/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $65.73 | General |
| Category: Nephrology | ||||||
| 04/05/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Consulting Fee | Cash or cash equivalent | $9,715.00 | General |
| 04/05/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Travel and Lodging | Cash or cash equivalent | $36.45 | General |
| 04/05/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | Cash or cash equivalent | $9.76 | General |
| 04/02/2024 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 03/08/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Travel and Lodging | In-kind items and services | $318.40 | General |
| 03/08/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 03/08/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 03/08/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $20.14 | General |
| 03/07/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Travel and Lodging | In-kind items and services | $489.40 | General |
| 03/07/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Travel and Lodging | In-kind items and services | $318.40 | General |
| 03/07/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Travel and Lodging | In-kind items and services | $232.08 | General |
| 03/07/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $147.56 | General |
| 02/09/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $7,600.00 | General |
| 02/09/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | Cash or cash equivalent | $551.48 | General |
| 02/09/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $215.76 | General |
| 02/09/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $209.97 | General |
| 02/08/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $414.89 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 208 | 505 | $49,260 | $10,542 |
| 2022 | 6 | 319 | 764 | $77,062 | $16,061 |
| 2021 | 6 | 270 | 673 | $67,318 | $14,876 |
| 2020 | 5 | 204 | 505 | $50,552 | $11,398 |
Total Patients
1,001
Total Services
2,447
Medicare Billing
$52,877
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Facility | 2023 | 43 | 286 | $24,310 | $6,003 | 24.7% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Facility | 2023 | 45 | 46 | $5,980 | $1,199 | 20.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 45 | 46 | $8,510 | $1,188 | 14.0% |
| 88348 | Electron microscopy for diagnosis | Facility | 2023 | 16 | 16 | $3,680 | $922.39 | 25.1% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 46 | 97 | $5,044 | $859.51 | 17.0% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 13 | 14 | $1,736 | $370.58 | 21.3% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Facility | 2022 | 63 | 416 | $36,210 | $8,620 | 23.8% |
| 88348 | Electron microscopy for diagnosis | Facility | 2022 | 34 | 34 | $7,820 | $1,929 | 24.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 68 | 73 | $13,060 | $1,847 | 14.1% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Facility | 2022 | 68 | 71 | $9,014 | $1,831 | 20.3% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2022 | 67 | 149 | $7,724 | $1,305 | 16.9% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 19 | 21 | $3,234 | $528.61 | 16.3% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Facility | 2021 | 54 | 385 | $32,725 | $8,473 | 25.9% |
| 88348 | Electron microscopy for diagnosis | Facility | 2021 | 32 | 32 | $7,360 | $1,761 | 23.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2021 | 57 | 61 | $11,285 | $1,679 | 14.9% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Facility | 2021 | 57 | 58 | $7,540 | $1,534 | 20.3% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2021 | 58 | 125 | $6,500 | $1,145 | 17.6% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2021 | 12 | 12 | $1,908 | $284.69 | 14.9% |
| 88350 | Antibody evaluation | Facility | 2020 | 43 | 288 | $24,480 | $6,336 | 25.9% |
| 88348 | Electron microscopy for diagnosis | Facility | 2020 | 25 | 26 | $5,980 | $1,531 | 25.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2020 | 45 | 50 | $9,250 | $1,432 | 15.5% |
| 88346 | Antibody evaluation | Facility | 2020 | 45 | 45 | $5,850 | $1,227 | 21.0% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2020 | 46 | 96 | $4,992 | $872.56 | 17.5% |
About Dr. Agnes Fogo, MD
Dr. Agnes Fogo, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720186679.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Agnes Fogo, MD has received a total of $233,442 in payments from pharmaceutical and medical device companies, with $28,096 received in 2024. These payments were reported across 104 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($199,970).
As a Medicare-enrolled provider, Fogo has provided services to 1,001 Medicare beneficiaries, totaling 2,447 services with total Medicare billing of $52,877. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location Nashville, TN
- Active Since 09/21/2006
- Last Updated 03/25/2022
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1720186679
Products in Payments
- Aranesp (Biological) $60,678
- ACTHAR (Biological) $29,865
- Repatha (Biological) $9,500
- BENLYSTA (Biological) $5,468
- TARPEYO (Drug) $2,801
- NO PRODUCT DISCUSSED (Drug) $585.00
- INVOKANA (Drug) $168.00
- SOLIRIS (Drug) $31.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in Nashville
Dr. Shirley Shiller, D.o, D.O
Anatomic Pathology & Clinical Pathology — Payments: $1.3M
Anatomic Pathology & Clinical Pathology $1.3M
Dr. Aml Girgis
Anatomic Pathology & Clinical Pathology — Payments: $160,000
Anatomic Pathology & Clinical Pathology $160,000
Pampee Young, Md, Phd, MD, PHD
Anatomic Pathology & Clinical Pathology — Payments: $59,171
Anatomic Pathology & Clinical Pathology $59,171
Bret Mobley, Md., M.s, MD., M.S
Anatomic Pathology & Clinical Pathology — Payments: $56,061
Anatomic Pathology & Clinical Pathology $56,061
Anne Neff, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $31,138
Anatomic Pathology & Clinical Pathology $31,138
David Gailani, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $25,944
Anatomic Pathology & Clinical Pathology $25,944